These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 31905227)
21. Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression. Oda S; Noda T; Wijesinghe KJ; Halfmann P; Bornholdt ZA; Abelson DM; Armbrust T; Stahelin RV; Kawaoka Y; Saphire EO J Virol; 2016 Feb; 90(4):1839-48. PubMed ID: 26656687 [TBL] [Abstract][Full Text] [Related]
22. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways. Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912 [TBL] [Abstract][Full Text] [Related]
23. Host Protein BAG3 is a Negative Regulator of Lassa VLP Egress. Han Z; Schwoerer MP; Hicks P; Liang J; Ruthel G; Berry CT; Freedman BD; Sagum CA; Bedford MT; Sidhu SS; Sudol M; Harty RN Diseases; 2018 Jul; 6(3):. PubMed ID: 30011814 [TBL] [Abstract][Full Text] [Related]
24. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Webb C; Upadhyay A; Giuntini F; Eggleston I; Furutani-Seiki M; Ishima R; Bagby S Biochemistry; 2011 Apr; 50(16):3300-9. PubMed ID: 21417403 [TBL] [Abstract][Full Text] [Related]
25. Characterization of filovirus protein-protein interactions in mammalian cells using bimolecular complementation. Liu Y; Stone S; Harty RN J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S817-24. PubMed ID: 21987757 [TBL] [Abstract][Full Text] [Related]
26. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866 [TBL] [Abstract][Full Text] [Related]
27. Nedd4 regulates egress of Ebola virus-like particles from host cells. Yasuda J; Nakao M; Kawaoka Y; Shida H J Virol; 2003 Sep; 77(18):9987-92. PubMed ID: 12941909 [TBL] [Abstract][Full Text] [Related]
28. Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. Dolnik O; Kolesnikova L; Stevermann L; Becker S J Virol; 2010 Aug; 84(15):7847-56. PubMed ID: 20504928 [TBL] [Abstract][Full Text] [Related]
29. A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner. Koehler A; Kolesnikova L; Welzel U; Schudt G; Herwig A; Becker S J Virol; 2016 Feb; 90(3):1444-54. PubMed ID: 26581998 [TBL] [Abstract][Full Text] [Related]
30. Host and Viral Proteins Modulating Ebola and Marburg Virus Egress. Gordon TB; Hayward JA; Marsh GA; Baker ML; Tachedjian G Viruses; 2019 Jan; 11(1):. PubMed ID: 30609802 [TBL] [Abstract][Full Text] [Related]
31. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression. Hsu YL; Hung JY; Chou SH; Huang MS; Tsai MJ; Lin YS; Chiang SY; Ho YW; Wu CY; Kuo PL Oncogene; 2015 Jul; 34(31):4056-68. PubMed ID: 25381822 [TBL] [Abstract][Full Text] [Related]
32. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection. Okumura A; Rasmussen AL; Halfmann P; Feldmann F; Yoshimura A; Feldmann H; Kawaoka Y; Harty RN; Katze MG J Virol; 2015 Oct; 89(20):10399-406. PubMed ID: 26246577 [TBL] [Abstract][Full Text] [Related]
33. Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention. Han Z; Madara JJ; Herbert A; Prugar LI; Ruthel G; Lu J; Liu Y; Liu W; Liu X; Wrobel JE; Reitz AB; Dye JM; Harty RN; Freedman BD PLoS Pathog; 2015 Oct; 11(10):e1005220. PubMed ID: 26513362 [TBL] [Abstract][Full Text] [Related]
34. Plasma membrane association facilitates conformational changes in the Marburg virus protein VP40 dimer. Bhattarai N; Gc JB; Gerstman BS; Stahelin RV; Chapagain PP RSC Adv; 2017 Apr; 7(37):22741-22748. PubMed ID: 28580138 [TBL] [Abstract][Full Text] [Related]
35. Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress. Loughran HM; Han Z; Wrobel JE; Decker SE; Ruthel G; Freedman BD; Harty RN; Reitz AB Bioorg Med Chem Lett; 2016 Aug; 26(15):3429-35. PubMed ID: 27377328 [TBL] [Abstract][Full Text] [Related]
37. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oka T; Schmitt AP; Sudol M Oncogene; 2012 Jan; 31(1):128-34. PubMed ID: 21685940 [TBL] [Abstract][Full Text] [Related]
38. High-Throughput Screening Assay to Identify Small Molecule Inhibitors of Marburg Virus VP40 Protein. Luthra P; Anantpadma M; De S; Sourimant J; Davey RA; Plemper RK; Basler CF ACS Infect Dis; 2020 Oct; 6(10):2783-2799. PubMed ID: 32870648 [TBL] [Abstract][Full Text] [Related]
39. Human transbodies to VP40 inhibit cellular egress of Ebola virus-like particles. Teimoori S; Seesuay W; Jittavisutthikul S; Chaisri U; Sookrung N; Densumite J; Saelim N; Chulanetra M; Maneewatch S; Chaicumpa W Biochem Biophys Res Commun; 2016 Oct; 479(2):245-252. PubMed ID: 27638305 [TBL] [Abstract][Full Text] [Related]
40. Identification of amino acids in Marburg virus VP40 that are important for virus-like particle budding. Makino A; Yamayoshi S; Shinya K; Noda T; Kawaoka Y J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S871-7. PubMed ID: 21987763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]